ANTIDOTE TREATMENT
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded Contract SPE2DP25F143B to DMS PHARMACEUTICAL GROUP INC CAGE 1UNB0 for the provision of ANTIDOTE TREATMENT identified by NSN 6505015984306 under the underlying contract SPE2DX15D9383. The award was issued on July 22, 2026, and the total contract value is specified in the associated award documentation. This delivery order is part of a federal procurement effort under the Department of Defense, with no set-aside designation applied. The item is intended for military use and will be delivered to an unspecified location within the United States. All contract details and performance information can be accessed via the official DIBBS portal using the provided UI link.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(2)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
